The Molecular Pharmaceutics & Drug Delivery Seminar Series Presents:
Dr. Diane J. Burgess, Distinguished Professor, Pfizer Distinguished Chair in Pharmaceutical Technology, University of Connecticut
Continuous Manufacturing Platform for Nanoparticle-Based Complex Parenteral Therapeutics
Tuesday, April 23, 2024
11:00 a.m. – 12:00 p.m.
PHR 4.114
In-Person/Hybrid
Dr. Diane J. Burgess
B.Sc. Pharmacy, University of Strathclyde (1979) and Ph.D. Pharmaceutics, University of London (1984). Fellow of AAPS, CRS, APSTJ, AIMBE and the National Academy of Inventors. 2010 CRS President; 2002 AAPS President. Editor of International Journal of Pharmaceutics (2009 – 2018). Editorial board member of 13 international journals. Recipient of: 2023 AAPS Alice E. Till Advancement of Women in Pharmaceutical Sciences Recognition; 2023 University of Connecticut AAUP Edward C. Marth Mentorship Award; 2018 AAPS Wurster Award in Pharmaceutics; 2014 AAPS Research Achievement Award; 2014 AAPS Outstanding Educator Award; 2014 CRS Distinguished Service Award; 2013 AAPS IPEC Ralph Shangraw Award; 2010 CRSI Fellowship, 2011 APSTJ Nagai International Woman Scientist Award. Over 280 refereed publications, over 730 research presentations, over 342 invited presentations, 29 keynote and plenary addresses. Founder, DIANT Pharma (2019). DIANT Pharma develops proprietary continuous manufacturing technology for nanoparticles with a wide array of applications throughout multiple industries, such as lipid nanoparticles and liposomes for pharmaceutical formulations. Inventor on 14 patents/patent applications, eleven of which have been licensed to companies and five products/product lines have already been commercialized.